Cancer Res Treat.
2023 Jul;55(3):1061-1061. 10.4143/crt.2021.1115.E.
ERRATUM: Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
- Affiliations
-
- 1Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- 2Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
- 3Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea
- 4Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
- 5Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
- 6Department of Genomic Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
- 7Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea
- 8Department of Oncology/Hematology, Kyungpook National University Chilgok Hospital, Daegu, Korea
- 9Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
- 10Department of Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
- 11Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
- 12Division of Medical Oncology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
- 13Center for Colorectal Cancer, National Cancer Center, Research Institute and Hospital, Goyang, Korea
- 14Department of Internal Medicine, Hallym University Medical Center, Hallym University, Anyang, Korea
- KMID: 2544187
- DOI: http://doi.org/10.4143/crt.2021.1115.E
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group
- Clinical Implication of Molecular Tumor Board
- Latest trends in cancer clinical trials using genomics
- Ultra-rare Disease and Genomics-Driven Precision Medicine
- The Cancer Precision Medicine Diagnosis and Treatment (K-MASTER) Enterprise
